Abbott Laboratories
ABTCompany Overview
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
This stock meets all Shariah compliance criteria according to AAOIFI standards.
| Name | Abbott Laboratories |
| Ticker | ABT |
| Main Business | Pharmaceutical Preparations |
| Type | Securities |
| Industry | Medical Devices |
| Country | US |
| Market Cap | $190.42 B |
Shariah Analysis Breakdown
| Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
|---|---|---|---|
| Established Pharmaceutical Products | $4,912.0 | $0.0 | - |
| Nutritional Products | $7,459.0 | $0.0 | - |
| Diagnostic Products | $16,584.0 | $0.0 | - |
| Medical Devices | $14,687.0 | $0.0 | - |
| Other | $11.0 | $11.0 | undefined |
| Interest income | $183.0 | $183.0 | - |
| Other Income | $321.0 | $321.0 | equity investment impairments |
| Total | $44,157.0 | $515.0 | 1.17% (passed) |
| Liability Item | Value ($M) | % of Market Cap |
|---|---|---|
| current debt and capital lease obligation | $1,080,000,000.0 | 0.57% |
| long term debt and capital lease obligation | $14,550,000,000.0 | 7.64% |
| Total Interest-Bearing Debt | $15,630,000,000.0 | 8.21% |
| Market Capitalization | $190,421,100,000.0 | 100.00% |
| Compliance Status | Threshold: 33% | passed |